FDA Drug Application (022090) for EOVIST by BAYER HLTHCARE

Back to FDA Applications sponsored by BAYER HLTHCARE

Application Number022090
Product Number001
FormSOLUTION;INTRAVENOUS
Dosage1.8143GM/10ML (181.43MG/ML)
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameEOVIST
Active IngredientGADOXETATE DISODIUM



Back to FDA Applications sponsored by BAYER HLTHCARE